July 17, 2026
Stuart Therapeutics Spotlights Topical RP Program
At OIS Retina, Eric Schlumpf discussed the company’s collagen mimetic peptide platform for retinitis pigmentosa, now in preclinical development.
American Society of Retina Specialists annual meeting
Related Content
July 17, 2026
Alkeus Launches Phase 3 Stargardt Trial
At OIS Retina, Carlos Quezada Ruiz, MD, highlighted the launch of the global phase 3 NORTHSTAR trial evaluating investigational oral gildeuretinol for Stargardt disease.
July 17, 2026
Neuroprotection: Retina's Next Frontier?
At OIS Retina in Montreal, Riad Sherif, MD, discussed Oculis’s optic neuritis program and why neuroprotection may represent the next frontier in retinal therapeutics.
July 16, 2026
CMS Proposal Would Cut Payment for Same-Day Injection Visits
The proposed Physician Fee Schedule for 2027 includes changes affecting intravitreal injections, E/M services, and physician payment.